Price (delayed)
$93.53
Market cap
$11.02B
P/E Ratio
39.8
Dividend/share
$0.28
EPS
$2.35
Enterprise value
$13.21B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.